| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |